Clinical Trial Update: Piperacillin Sodium and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update of Piperacillin Sodium and Sulbactam Sodium for Injection (2:1) for treating respiratory tract infections and urinary tract infect…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Tract Infections
• Urinary Tract Infections

Drugs mentioned

• Piperacillin Sodium and Sulbactam Sodium for Injection (2:1) (piperacillin and sulbactam)

Snippet

Sponsor: Xiangbei Welman Pharmaceutical Co., Ltd | Conditions: Respiratory Tract Infections, Urinary Tract Infections | Phase 4 | Status: UNKNOWN